Modelling of fasting glucose-insulin dynamics from sparse data*

With the fast growth of diabetes prevalence, the disease is now considered an epidemic. Diabetes is characterized by elevated glucose levels, that may be treated with insulin. Tight control of glucose is essential for prevention of complications and patients’ well-being. In this paper we model the fasting glucose-insulin dynamics in type 2 diabetes, aiming at controlling the glucose level. Relevant clinical data are typically sparse and have a sampling period much greater than the fast dynamics in the glucose-insulin dynamics in humans. We adapt a physiological model such that important slow non-linear dynamics are identifiable and test the resulting model on deterministic simulated data and sparse, slow sampled clinical data.

[1]  A. De Gaetano,et al.  Mathematical models of diabetes progression. , 2008, American journal of physiology. Endocrinology and metabolism.

[2]  B. Zinman,et al.  Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes , 2012, Diabetes Care.

[3]  C Cobelli,et al.  Quantitative Estimation of Beta Cell Sensitivity to Glucose in the Intact Organism: A Minimal Model of Insulin Kinetics in the Dog , 1980, Diabetes.

[4]  Jochen Sieber,et al.  Common Standards of Basal Insulin Titration in T2DM , 2013 .

[5]  Garry M. Steil,et al.  Identification of Intraday Metabolic Profiles during Closed-Loop Glucose Control in Individuals with Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[6]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[7]  Sten Bay Jørgensen,et al.  Parameter estimation in stochastic grey-box models , 2004, Autom..

[8]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.

[9]  Claudio Cobelli,et al.  Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.

[10]  P. Hogan,et al.  Economic Costs of Diabetes in the U , 2013 .

[11]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[12]  Henrik Bengtsson,et al.  Model for Simulating Fasting Glucose in Type 2 Diabetes and the Effect of Adherence to Treatment. , 2017 .

[13]  Mats O Karlsson,et al.  Modeling of 24‐Hour Glucose and Insulin Profiles of Patients With Type 2 Diabetes , 2011, Journal of clinical pharmacology.